We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
CRH
CRH
$66.8B
| $3.34M | 0.02% |
71,420
+1,170
| +2% | +$59.3K |
|
|
EFT
602
Eaton Vance Floating-Rate Income Trust
EFT
$288M
| $3.34M | 0.02% |
229,086
+13,564
| +6% | +$199K |
|
603
WisdomTree US MidCap Dividend Fund
DON
$4.09B
| $3.33M | 0.02% |
80,251
+37,508
| +88% | +$1.57M |
|
604
SAP
SAP
$238B
| $3.32M | 0.02% |
24,601
+204
| +0.8% | +$29.6K |
|
605
A.O. Smith
AOS
$8.7B
| $3.32M | 0.02% |
54,348
+9,494
| +21% | +$663K |
|
606
Zebra Technologies
ZBRA
$17.8B
| $3.3M | 0.02% |
6,406
+2,169
| +51% | +$1.21M |
|
607
S&P Global
SPGI
$120B
| $3.3M | 0.02% |
7,763
-442
| -5% | -$192K |
|
|
WRK
608
DELISTED
WestRock Company
WRK
| $3.29M | 0.02% |
66,144
+62,430
| +1,681% | +$3.15M |
|
609
Snap
SNAP
$9.01B
| $3.27M | 0.02% |
44,305
+8,627
| +24% | +$623K |
|
610
Illumina
ILMN
$28.4B
| $3.25M | 0.02% |
8,248
-130
| -2% | -$59.8K |
|
611
Newmont
NEM
$119B
| $3.25M | 0.02% |
59,881
+5,278
| +10% | +$311K |
|
612
State Street SPDR S&P Global Infrastructure ETF
GII
$932M
| $3.25M | 0.02% |
61,548
| – | – |
|
613
Equity Lifestyle Properties
ELS
$12.6B
| $3.24M | 0.02% |
41,543
-443
| -1% | -$36.3K |
|
614
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
| $3.23M | 0.02% |
18,389
-2,228
| -11% | -$396K |
|
615
Seagate
STX
$184B
| $3.22M | 0.02% |
39,089
+5,922
| +18% | +$515K |
|
616
Alerian MLP ETF
AMLP
$12.8B
| $3.21M | 0.02% |
96,199
-3,476
| -3% | -$116K |
|
617
Cemex
CX
$16.3B
| $3.16M | 0.02% |
440,347
+40,382
| +10% | +$319K |
|
618
Edison International
EIX
$26.4B
| $3.15M | 0.02% |
56,865
+1,745
| +3% | +$100K |
|
619
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.5B
| $3.12M | 0.02% |
48,801
+13,379
| +38% | +$883K |
|
620
Mueller Water Products
MWA
$4.17B
| $3.12M | 0.02% |
204,959
+202,197
| +7,321% | +$3.11M |
|
621
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $3.11M | 0.02% |
51,680
+10,834
| +27% | +$660K |
|
622
First Trust Energy AlphaDEX Fund
FXN
$368M
| $3.1M | 0.02% |
270,095
+207,077
| +329% | +$2.19M |
|
623
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
| $3.09M | 0.02% |
74,384
+12,820
| +21% | +$533K |
|
624
Ginkgo Bioworks
DNA
$521M
| $3.07M | 0.02% |
+6,622
| New | +$3.22M |
|
625
Paychex
PAYX
$42.7B
| $3.06M | 0.02% |
27,251
-29,197
| -52% | -$3.28M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.